Abstract

We present the Cancer Moonshot clinical project located at the European center in Lund. Here, tissue and blood samples have been collected and stored in a large-scale biobank. Multiple clinical centers around the world are participating and tissue and blood samples are sent to the European Cancer Moonshot Lund Center that acts as the clinical hub. Our center has been developed to generate and build large-scale biostorage archives of patient melanoma samples, which is then combined with a histopathological capability to characterize the patient tumours. Such a large-scale clinical sample processing initiative has begun with the aim of creating high-end histopathology indexing with database computational power and including proteogenomic analysis. The biobank at Lund has become an important resource in clinical research worldwide. Following suite, several national health programs are being initiated with the aim of also building large-scale biobank storages with a wealth of high-quality patient samples. In our Cancer Moonshot R&D activities, samples in the biobanks and the data derived from these samples are being used to build an understanding of disease presentation and using this information to move towards ‘Big Data’ proteogenomic and mass spectrometry imaging studies. Additionally, we report here a sample processing workflow that has been adapted to a fully-automated biobank processing strategy for large-scale studies.

Highlights

  • Today, cancer impact by optimal treatment is already at the front line worldwide with the latest immuno- and cell therapies

  • Recent reports have indicated that the rate of sample collection is in the order of 20 million samples per year [1, 2]

  • *Correspondence: johan.malm@med.lu.se 1 Department of Translational Medicine, Section for Clinical Chemistry, Lund University, Skåne University Hospital Malmö, 205 02 Malmö, Sweden Full list of author information is available at the end of the article with cancer of any type in the United States (2014)

Read more

Summary

Introduction

Cancer impact by optimal treatment is already at the front line worldwide with the latest immuno- and cell therapies. *Correspondence: johan.malm@med.lu.se 1 Department of Translational Medicine, Section for Clinical Chemistry, Lund University, Skåne University Hospital Malmö, 205 02 Malmö, Sweden Full list of author information is available at the end of the article with cancer of any type in the United States (2014). The biobanking developments within the Cancer Moonshot activities in Lund have been given top priority to provide high-quality and well-defined tissue and biofluid specimens [7–9].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call